Anne North
5Patents
3h-index
6Co-inventors
50Inventor score
Filing activity: May 15, 1998 → Sep 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8900805B2 | Quenching methods for red blood cell pathogen inactivation | Human Necessities | 13 | Active |
| US9713627B2 | Pathogen-inactivated red blood cell compositions | Human Necessities | 12 | Active |
| US10357516B2 | Pathogen-inactivated red blood cell compositions | Human Necessities | 10 | Active |
| US6340575B1 | Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity | Human Necessities | 1 | Expired |
| US12282015B2 | Systems and methods for testing and screening using compound bound substrates | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.